Parenchymal Volume Replacement by Renal Cell Carcinoma Prior to Intervention: Predictive Factors and Functional Implications

Urology. 2022 Jan:159:139-145. doi: 10.1016/j.urology.2021.09.010. Epub 2021 Oct 2.

Abstract

Objective: To analyze predictors, extent and functional implications associated with renal parenchymal volume replacement (PVR) by renal cell carcinoma (RCC) prior to intervention. This phenomenon is well-recognized yet not adequately studied, and, if severe, can influence management.

Materials and methods: A retrospective review was performed of partial nephrectomy (PN) and radical nephrectomy (RN) patients with available preoperative nuclear-renal-scan and imaging demonstrating solitary RCC with normal contralateral kidney. Normal renal parenchymal volume of each kidney was measured by free-hand scripting from preoperative axial images. Primary endpoint was percent PVR which was estimated assuming that the contralateral-kidney serves as a control: PVR = (volume contralateral kidney - volume ipsilateral kidney) normalized by volume contralateral kidney. Multivariable linear-regression analysis assessed factors associated with preoperative PVR. Further analysis evaluated the functional effect of PVR prior to surgery.

Results: 146 PN and 136 RN patients with necessary studies were analyzed. For RN, the median PVR was 15% and a quarter of patients had PVR ≥27%. In contrast, PVR was negligible in PN patients for whom median preoperative parenchymal volumes were nearly identical in the ipsilateral/contralateral kidneys (179/180cc, respectively). PVR inversely correlated with preoperative renal function in the ipsilateral kidney (P <.01). Tumor-size (P <.01), stage (P = .03), and endophytic properties (P = .03) associated with PVR on multivariable-analysis.

Conclusion: Our data suggest that substantial replacement of normal parenchyma by RCC occurs in many patients selected for RN and can contribute to preexisting renal-insufficiency. PVR prior to intervention is mainly driven by tumor characteristics in RN patients, but is negligible in most PN patients.

MeSH terms

  • Carcinoma, Renal Cell* / pathology
  • Carcinoma, Renal Cell* / physiopathology
  • Carcinoma, Renal Cell* / surgery
  • Female
  • Humans
  • Kidney Function Tests / methods
  • Kidney Neoplasms* / pathology
  • Kidney Neoplasms* / physiopathology
  • Kidney Neoplasms* / surgery
  • Kidney* / diagnostic imaging
  • Kidney* / physiopathology
  • Male
  • Middle Aged
  • Neoplasm Invasiveness* / diagnostic imaging
  • Neoplasm Invasiveness* / pathology
  • Neoplasm Invasiveness* / physiopathology
  • Neoplasm Staging
  • Nephrectomy* / adverse effects
  • Nephrectomy* / methods
  • Organ Size
  • Parenchymal Tissue* / diagnostic imaging
  • Parenchymal Tissue* / pathology
  • Preoperative Care* / methods
  • Preoperative Care* / statistics & numerical data
  • Prognosis
  • Renal Insufficiency / diagnosis
  • Renal Insufficiency / etiology
  • Tomography, X-Ray Computed / methods
  • Tumor Burden